John Peter Walker

This profile gathers the share dealings of John Peter Walker across 5 companies, led by Paratek Pharmaceuticals, Inc., Geron Corp and Renovis Inc. Between 27 February 2006 and 25 June 2020, the trades on record add up to 117 filings.

Both buying and selling appear: 47 purchases worth €710k, against 51 sales worth €867k. The net balance comes to €157k on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 9 share grants and 8 option exercises.

In size, the median ticket on the buying side is €1,412. Clusters matter here: 3 out of 4 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 29 June 2020, the filings show a share grant in Zosano Pharma Corp. The last purchase on record was published on 18 April 2019, which is 2,745 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.